nw LA: Perhaps CYGX no longer possesses the current "state of the art" science in synthetic DNA or anything else. I think their day has come and gone, cut short by management hubris and a severe lack of capital. I don't see how the company can survive unless they receive some angel funding or an unexpected government contract for some substantial dollars. At 11 cents a share they need to sell 50 MILLION more shares just to pay for the building and survive until the end of 2008. Do the math. Do you think there are buyers for another 50 MILLION shares with the track record of CYGX over the last 21 months. I don't. But you can keep on hoping.
News 
Market Data 
Discover 
